UCSF Medical Center Adopts Hi-Tech "Smart" Dressing for Chronic Wounds

University of California San Francisco Medical Center adopts the first in its class self-adaptive wound dressing for treating chronic wounds

News provided by

OSNovative Systems, Inc.

Oct 21, 2014, 11:02 ET

SANTA CLARA, Calif., Oct. 21, 2014 /PRNewswire/ -- OSNovative Systems, Inc., the maker of self-adaptive wound care dressings, announced today that its award-winning ENLUXTRA^TM"Any Wound" dressing has been adopted at the UCSF Medical Center for treating chronic wounds.

In the United States, the burden of managing chronic wounds is growing rapidly due to an aging population and the increased incidence of diabetes, obesity and associated co-morbidities:

Best Innovation of 2014. In one year ENLUXTRA "Any Wound" Self-Adaptive Wound Dressing received two awards for its innovative approach to wound care. Based on Frost & Sullivan's independent analysis of the North American Wound Care Dressing market, ENLUXTRA "Any Wound" is recognized with the 2014 New Product Innovation Leadership Award. "Enluxtra(TM), provides better clinical outcomes, remarkably simplifies wound care procedures and significantly reduces cost of care."

About seven million patients suffer from chronic wounds
$25 billion is spent annually on chronic wound management
Over half of all foot ulcers become infected, requiring hospitalization; one in five require an amputation
Diabetic foot ulcers double the mortality risk
Infected wounds are dangerous and may result in sepsis and death in chronic wound patients

Clinical effectiveness and affordability of the first "smart" wound care product featuring feedback-driven, polymeric dressing material take wound management to a radically new level.

Enluxtra represents a fundamentally new category of dynamic, multifunctional, self-adaptive wound care products. While in direct contact with the wound, the dressing material analyzes the wound condition; it then automatically and reversibly adjusts its function to accommodate the wound's needs, which may frequently and unpredictably change.

Absorbed exudate and pathogens are locked inside the dressing, controlling infection and maceration; the dressing material releases moisture to dry areas of the wound, preventing desiccation. In effect, Enluxtra is suitable for any wound type at any healing stage.

"What's impressive about this dressing is that you can use it from beginning to end on any wound," said Dr. Alex Reyzelman, the Co-Director of UCSF Center for Limb Preservation. "Now we can carry one product and use it on almost everything."

The super-absorptive dressing can be worn for up to 10 days, which results in both economic and clinical benefits. Reduced dressing change frequency brings significant cost savings to patients and healthcare providers, while fewer disruptions of wound homeostasis (a known critical condition for fast wound healing) aid uninterrupted healing process.

"One of the big challenges in wound care is keeping the wound at that "just right" level of moisture -- not too wet and not too dry," said Dr. Caroline Fife, the Medical Director of the Wound Clinic at St. Luke's Hospital, The Woodlands, TX, and a prominent figure in the national wound care industry. "Enluxtra adapts to the changes in the amount of wound fluid, and patients love the way it feels. Enluxtra doesn't stick to the wound, it is easy to apply and it is comfortable."

The impact Enluxtra can make on the economics of wound management stems from three major factors: inventory reduction, simplified training (even patients themselves can use the product), and reduced treatment duration.

Economic factors aside, Enluxtra does more: it brings long-awaited relief to chronic wound sufferers, changing and saving people's lives.

"So far, out of all the things I've tried in all my years – and I've been treating wounds for 15 years – this is as close as it comes to a perfect dressing right now," Dr. Reyzelman said. "I'm very excited about it because it's actually doing what it's designed to do."

In almost two years on the market, Enluxtra has been used by more than 40,000 patients both at home and in leading healthcare organizations and hundreds of facilities nationwide, including major hospitals, long-term care and skilled nursing facilities, nursing homes, home health agencies, wound care and podiatry clinics.

About OSNovative Systems
OSNovative Systems, Inc. is a rapidly growing Silicon Valley start-up. The company develops, manufactures and sells proprietary devices for advanced wound management, combat/emergency medicine and cosmetic skin care. OSNovative Systems is headquartered in Santa Clara, Calif. For more information, visit www.AnyWound.com.

UC Disclaimer
The information stated above was prepared by OSNovative Systems and reflects solely the opinion of the corporation. Nothing in this statement shall be construed to imply any support or endorsement of OSNovative Systems, or any of its products, by The Regents of the University of California, its officers, agents and employees.

Photo - http://photos.prnewswire.com/prnh/20141021/153390

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ucsf-medical-center-adopts-hi-tech-smart-dressing-for-chronic-wounds-564657844.html

SOURCE OSNovative Systems, Inc.